| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 7904 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 6395* | 2020 |
| Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic … H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ... The Lancet 396 (10258), 1160-1203, 2020 | 1275 | 2020 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1107 | 2022 |
| The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ... The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019 | 835* | 2019 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 545 | 2020 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 336 | 2021 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 263 | 2022 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 167 | 2022 |
| Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran AM Alizadeh, G Roshandel, S Roudbarmohammadi, M Roudbary, ... Asian Pacific journal of cancer prevention 13 (6), 2625-2628, 2012 | 156 | 2012 |
| Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 JL Ward, PS Azzopardi, KL Francis, JS Santelli, V Skirbekk, SM Sawyer, ... The Lancet 398 (10311), 1593-1618, 2021 | 139 | 2021 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 134 | 2022 |
| Anemia prevalence in women of reproductive age in low-and middle-income countries between 2000 and 2018 D Kinyoki, AE Osgood-Zimmerman, NV Bhattacharjee, NJ Kassebaum, ... Nature medicine 27 (10), 1761-1782, 2021 | 109 | 2021 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 Nature medicine 26 (5), 750-759, 2020 | 108 | 2020 |
| Mapping routine measles vaccination in low-and middle-income countries Nature 589 (7842), 415-419, 2021 | 86 | 2021 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 45 | 2024 |
| Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers A Taherkhani, R Farrokhi Yekta, M Mohseni, M Saidijam, A Arefi Oskouie Proteome science 17, 1-18, 2019 | 40 | 2019 |
| Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs H Manoochehri, A Jalali, H Tanzadehpanah, A Taherkhani, R Najafi Colloids and Surfaces B: Biointerfaces 218, 112714, 2022 | 26 | 2022 |
| Molecular docking study of flavonoid compounds for possible matrix metalloproteinase-13 inhibition A Taherkhani, S Moradkhani, A Orangi, A Jalalvand, Z Khamverdi Journal of Basic and Clinical Physiology and Pharmacology 32 (6), 1105-1119, 2021 | 26 | 2021 |
| Identification of key gene targets for sensitizing colorectal cancer to chemoradiation: an integrative network analysis on multiple transcriptomics data H Manoochehri, A Jalali, H Tanzadehpanah, A Taherkhani, M Saidijam Journal of gastrointestinal cancer 53 (3), 649-668, 2022 | 25 | 2022 |
